Can a beam of light banish toenail fungus?
NCT ID NCT07756671
First seen Aug 11, 2026 · Last updated Sep 04, 2026 · Updated 3 times
Summary
This trial tests whether photodynamic therapy (PDT) can clear toenail fungus. People with a confirmed fungal nail infection will have a special gel applied to the affected nail, then exposed to red light. The study will check if the nail looks healthy and if the fungus is gone at several follow-up points over a year.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Photodynamic therapy using aminolevulinic acid (ALA) 10% gel and red light, with urea pretreatment
- What this could lead to
- If successful, this could offer a non-drug, light-based option for clearing toenail fungus, potentially helping people who can't take oral antifungals.
- What could go wrong
- This is a very small early-phase trial (5 people), so results may not apply broadly. The treatment may not fully clear the infection, and side effects like skin reactions are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1
The first testing in people. Mainly checks safety and dose, usually in a small group.
- Participants
-
About 5 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Clinical and mycological diagnosis \[by potassium hydroxide (KOH) stain\] of onychomycosis Exclusion Criteria: * Known or suspected allergies or sensitivities to any components of any of the study drugs * Patients with coagulation disorders * Known or suspected claustrophobia * Pregnancy during the treatment period * Medically unable to consent * Employees of the clinics * Prisoners
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Onychomycosis of toenail are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
3 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Arlington Center for Dermatology
RECRUITINGArlington, Texas, 76011, United States
-
Houston Skin
NOT_YET_RECRUITINGHouston, Texas, 77004, United States
-
Houston Skin
NOT_YET_RECRUITINGWebster, Texas, 77598, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily nail film clear stubborn toenail fungus?
- Can a Super-Strength nail paint beat stubborn toenail fungus?
- New light therapy takes on stubborn toenail fungus
- Light shines on fungus: new device tackles toenail infection
- New gel could beat toenail fungus faster
- New topical drug could tackle stubborn toenail fungus